FCA
NVS icon

FinTrust Capital Advisors’s Novartis NVS Stock Holding History

FinTrust Capital Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$165K Sell
1,435
-11
-0.8% -$1.25K 0.03% 339
2024
Q2 		$154K Buy
1,446
+72
+5% +$7.23K 0.03% 327
2024
Q1 		$133K Sell
1,374
-330
-19% -$33.8K 0.03% 345
2023
Q4 		$172K Hold
1,704
– – 0.03% 293
2023
Q3 		$174K Buy
1,704
+584
+52% +$59.3K 0.04% 277
2023
Q2 		$102K Hold
1,120
– – 0.02% 347
2023
Q1 		$102K Hold
1,120
– – 0.02% 344
2022
Q4 		$102K Buy
1,120
+500
+81% +$42.1K 0.02% 344
2022
Q3 		$48K Sell
620
-6
-1% -$497 0.01% 516
2022
Q2 		$54K Buy
626
+4
+0.6% +$351 0.01% 515
2022
Q1 		$54K Sell
622
-194
-24% -$16.8K 0.01% 546
2021
Q4 		$71K Sell
816
-700
-46% -$58.1K 0.02% 491
2021
Q3 		$124K Buy
1,516
+216
+17% +$19.4K 0.03% 365
2021
Q2 		$119K Buy
1,300
+255
+24% +$22.7K 0.03% 381
2021
Q1 		$89K Sell
1,045
-561
-35% -$50.3K 0.03% 443
2020
Q4 		$152K Buy
1,606
+26
+2% +$2.27K 0.05% 296
2020
Q3 		$137 Buy
1,580
+470
+42% +$40.7K 0.03% 307
2020
Q2 		$97K Buy
1,110
+192
+21% +$16.6K 0.04% 341
2020
Q1 		$76K Buy
918
+480
+110% +$42.8K 0.04% 337
2019
Q4 		$41K Buy
438
+21
+5% +$1.88K 0.02% 478
2019
Q3 		$36K Sell
417
-13
-3% -$1.17K 0.01% 522
2019
Q2 		$40K Sell
430
-483
-53% -$40.9K 0.02% 457
2019
Q1 		$78K Sell
913
-897
-50% -$72K 0.03% 315
2018
Q4 		$139K Buy
+1,810
New +$141K 0.07% 220

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FinTrust Capital Advisors's NVS Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Novartis (NVS) stake by 0.76% in Q3 2024, selling an estimated $1.25K and leaving 1,435 shares worth $165K. The position accounts for 0.03% of the portfolio, ranked #339.

FinTrust Capital Advisors first reported a position in NVS in Q4 2018 and has held it in 24 quarters since. The position peaked at $174K in Q3 2023. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • FinTrust Capital Advisors held 1,435 shares of Novartis worth $165K as of Q3 2024.
  • FinTrust Capital Advisors sold 11 Novartis shares in Q3 2024, an estimated $1.25K.
  • Novartis made up 0.03% of FinTrust Capital Advisors's portfolio in Q3 2024, its #339 holding.
  • FinTrust Capital Advisors first reported a position in Novartis in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's Novartis position peaked at $174K in Q3 2023.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.